Lux Health Tech Acquisition - Warrants(30/11/2027) Return on Equity

Lux Health Tech Acquisition - Warrants(30/11/2027) (LUXAW) currently reports a ROE of -213.75%. That is below the sector sector average of -4.47%. Use the charts on this page to explore Lux Health Tech Acquisition - Warrants(30/11/2027)'s ROE history and peer comparisons.

Lux Health Tech Acquisition - Warrants(30/11/2027)'s ROE of -213.75% is lower than the its sector sector average of -4.47%. That is roughly 4683.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Lux Health Tech Acquisition - Warrants(30/11/2027)'s current -213.75% should be judged against industry norms (sector average: -4.47%) and against LUXAW's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -213.75%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -4.47%. From there, open related valuation or income-statement pages for Lux Health Tech Acquisition - Warrants(30/11/2027), and consider following LUXAW for alerts when major investors trade the stock.